ID
22408
Description
Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV; ODM derived from: https://clinicaltrials.gov/show/NCT00614965
Link
https://clinicaltrials.gov/show/NCT00614965
Keywords
Versions (1)
- 6/2/17 6/2/17 -
Uploaded on
June 2, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non Small Cell Lung Cancer NCT00614965
Eligibility Non Small Cell Lung Cancer NCT00614965
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
mental disorder, social situation, compliance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004936
- UMLS CUI [1,2]
- C0748872
- UMLS CUI [1,3]
- C1321605
- UMLS CUI [1,4]
- C0525058
Description
concurrent uncontrolled illness
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0205318
Description
prior malignancy, nonmelanoma skin cancer
Data type
boolean
Alias
- UMLS CUI [1]
- C2735088
- UMLS CUI [2]
- C3281209
Similar models
Eligibility Non Small Cell Lung Cancer NCT00614965
- StudyEvent: Eligibility
C1708063 (UMLS CUI [1,2])
C0796493 (UMLS CUI [1,3])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0373595 (UMLS CUI [2])
C0428772 (UMLS CUI [3])
C0748872 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
C0205318 (UMLS CUI [1,2])
C3281209 (UMLS CUI [2])
No comments